{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:33:55Z","timestamp":1790771635629,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejca.2025.115592","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:45:20Z","timestamp":1750819520000},"page":"115592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-6755","authenticated-orcid":false,"given":"Federico","family":"Monaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-2491","authenticated-orcid":false,"given":"Igor","family":"Gomez-Randulfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9732","authenticated-orcid":false,"given":"Gerard","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cantale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-1297","authenticated-orcid":false,"given":"Ana","family":"Parreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariantonietta","family":"Di Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7224-2111","authenticated-orcid":false,"given":"Vito","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-547X","authenticated-orcid":false,"given":"Emanuele","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Blackhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-9748","authenticated-orcid":false,"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9781","authenticated-orcid":false,"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-5319","authenticated-orcid":false,"given":"Raffaele","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115592_bib1","article-title":"Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.ejca.2025.115592_bib2","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum\u2013etoposide versus platinum\u2013etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9962","key":"10.1016\/j.ejca.2025.115592_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejca.2025.115592_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cllc.2015.09.007","article-title":"Thoracic radiotherapy for extensive stage small-cell lung cancer: a meta-analysis","volume":"17","author":"Palma","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2025.115592_bib6","first-page":"292","article-title":"Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?","volume":"4","author":"Slotman","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2025.115592_bib7","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.21037\/tlcr-23-294","article-title":"Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis","volume":"12","author":"Cai","year":"2023","journal-title":"Transl Lung Cancer Res"},{"issue":"17","key":"10.1016\/j.ejca.2025.115592_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70175","article-title":"Impact of thoracic radiotherapy on first-line treatment outcomes in ES -SCLC patients","volume":"13","author":"Mu","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-024-02420-x","article-title":"Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis","volume":"19","author":"Yao","year":"2024","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13014-023-02308-2","article-title":"Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer","volume":"18","author":"Peng","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115592_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289434","article-title":"Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy","volume":"14","author":"Longo","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12672-023-00666-7","article-title":"Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center","volume":"14","author":"Li","year":"2023","journal-title":"Discov Oncol"},{"key":"10.1016\/j.ejca.2025.115592_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109934","article-title":"Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy","volume":"189","author":"Yang","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115592_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2025.115592_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2729","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.115592_bib16","unstructured":"Buffett Cancer Center P, Loo BW, Chair V, et al. NCCN guidelines version 4.2025 small cell lung cancer continue NCCN guidelines panel disclosures \u2021 Hematology\/Hematology Oncology \u00de Internal Medicine \u2020 Medical Oncology \u2260 Pathology \u00a5 Patient Advocacy \u039e Pulmonary Medicine \u00a7 Radiotherapy\/Radiation Oncology \u00b6 Surgery\/Surgical Oncology * Discussion Writing Committee Member; 2025. \u3008https:\/\/www.nccn.org\/home\/member-\u3009."},{"issue":"4","key":"10.1016\/j.ejca.2025.115592_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21037\/atm-20-5765","article-title":"Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejca.2025.115592_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.lungcan.2017.03.007","article-title":"Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: a secondary analysis of the Phase III CREST trial","volume":"108","author":"Slotman","year":"2017","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ejca.2025.115592_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"issue":"9975","key":"10.1016\/j.ejca.2025.115592_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0140-6736(15)60679-1","article-title":"Radiotherapy for extensive stage small-cell lung cancer \u2013 authors\u2019 reply","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115592_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lungcan.2018.08.016","article-title":"Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): a National Cancer Database (NCDB) propensity-matched analysis","volume":"124","author":"Hasan","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.115592_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13014-021-01773-x","article-title":"Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations","volume":"16","author":"Han","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115592_bib24","unstructured":"Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumab) for extensive stage small cell lung cancer. The RAPTOR Trial - \u3008https:\/\/clinicaltrials.gov\/study\/NCT04402788\u3009."},{"key":"10.1016\/j.ejca.2025.115592_bib25","doi-asserted-by":"crossref","first-page":"S1060","DOI":"10.1016\/j.annonc.2023.09.1219","article-title":"1988MO recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data","volume":"34","author":"Bozorgmehr","year":"2023","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925003740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925003740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:53:13Z","timestamp":1755003193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925003740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"alternative-id":["S0959804925003740"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115592","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115592"}}